scispace - formally typeset
W

Winnie Yeo

Researcher at The Chinese University of Hong Kong

Publications -  291
Citations -  19511

Winnie Yeo is an academic researcher from The Chinese University of Hong Kong. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 60, co-authored 282 publications receiving 16440 citations. Previous affiliations of Winnie Yeo include University of Hong Kong.

Papers
More filters
Journal ArticleDOI

Moderate coffee consumption reduces the risk of hepatocellular carcinoma in hepatitis B chronic carriers: a case–control study

Winnie W. Leung, +5 more
- 01 Jun 2011 - 
TL;DR: Evidence is provided to support the protective effect of coffee consumption in moderate quantities in HBV chronic carriers, a group at high risk of developing liver cancer.
Journal ArticleDOI

Impact of antitumor activity on survival outcomes, and nonconventional benefit, with nivolumab (NIVO) in patients with advanced hepatocellular carcinoma (aHCC): Subanalyses of CheckMate-040.

Anthony B. El-Khoueiry, +16 more
- 26 Feb 2018 - 
TL;DR: NIVO (anti–PD-1 mAb) has demonstrated durable responses, long-term OS, and manageable safety in pts with aHCC in CheckMate-040 and with anti–PD–1 thera...
Journal ArticleDOI

Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation

Ivy H.N. Wong, +4 more
- 26 Jun 2001 - 
TL;DR: Evidence is shown that HCC cells disseminating mostly post-treatment may be the 'seed' of recurrence/metastasis and sequential afp-mRNA quantification could predict clinical metastasis/recurrence in 56% of patients during a 4-year follow-up.
Journal ArticleDOI

Novel therapeutic potential in targeting microtubules by nanoparticle albumin-bound paclitaxel in hepatocellular carcinoma.

Qian Zhou, +9 more
- 01 Mar 2011 - 
TL;DR: The findings in this study highly suggest that the microtubule assembly represents a promising therapeutic target development in HCC.
Journal ArticleDOI

Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance.

Philip J. Johnson, +12 more
- 14 Feb 2017 - 
TL;DR: Variation in survival in hepatocellular carcinoma is largely accounted for by stage at diagnosis, which in turn relates to the intensity of surveillance programmes and the consequent variation in curative therapeutic options.